Combined inhibition of CDK and HDAC as a promising therapeutic strategy for both cutaneous and uveal metastatic melanoma

Very little to no improvement in overall survival has been seen in patients with advanced non-resectable cutaneous melanoma or metastatic uveal melanoma in decades, highlighting the need for novel therapeutic options. In this study we investigated as a potential novel therapeutic intervention for bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Heijkants, Renier, Willekens, Karen, Schoonderwoerd, Mark, Teunisse, Amina, Nieveen, Maaike, Radaelli, Enrico, Hawinkels, Luuk, Marine, Jean-Christophe, Jochemsen, Aart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814203/
https://www.ncbi.nlm.nih.gov/pubmed/29464063
http://dx.doi.org/10.18632/oncotarget.23485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814203/
https://www.ncbi.nlm.nih.gov/pubmed/29464063
http://dx.doi.org/10.18632/oncotarget.23485

Ejemplares similares